EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer

The EMA's CHMP has recommended approval of a combination therapy of BMS's Opdivo and Yervoy for the treatment of colorectal cancer.

Nov 19, 2024 - 06:00

EMA’s CHMP to approve BMS’ Opdivo for colorectal cancer

The EMA's CHMP has recommended approval of a combination therapy of BMS's Opdivo and Yervoy for the treatment of colorectal cancer.

Read the original article

Tags:

Previous Article

AHA 2024: lerodalcibep provides promising results in open-label extension trial,...

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

FDA backs Astellas-Pfizer’s Padcev with Keytruda for urothelial cancer

FDA backs Astellas-Pfizer’s Padcev with Keytruda for ur...

Dec 18, 2023

GC Therapeutics secures $65m to launch into off-the-shelf iPSC therapy space

GC Therapeutics secures $65m to launch into off-the-she...

Sep 22, 2024

South Korea seeks to accelerate drug reimbursement administration process

South Korea seeks to accelerate drug reimbursement admi...

Jun 22, 2024